1. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Issue 3 (21st June 2022) Authors: Chu, Xiaoyan; Prasad, Bhagwat; Neuhoff, Sibylle; Yoshida, Kenta; Leeder, James Steven; Mukherjee, Dwaipayan; Taskar, Kunal; Varma, Manthena V. S.; Zhang, Xinyuan; Yang, Xinning; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity. Issue 3 (30th November 2021) Authors: Dinh, Jean C.; Boone, Erin C.; Staggs, Vincent S.; Pearce, Robin E.; Wang, Wendy Y.; Gaedigk, Roger; Leeder, James Steven; Gaedigk, Andrea Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 3(2022) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗